Tosaf Completes Acquisition of Adtec Colorant in the US

Israel’s Tosaf Group, a manufacturer of plastics additives, compounds and color masterbatches, has finalized the acquisition of US-based Adtec Colorant. Located in Arlington, Texas, Adtec manufactures specialty color concentrates, liquid and additive masterbatches for the injection-molding, blow-molding, film and extrusion markets. Financial terms were not disclosed.

Amos Megides, Tosaf’s chairman and CEO, commented: “This transaction represents another step in the fulfilment of our US market entry strategy following our earlier announcement of the construction of a new additives, white and color masterbatch plant in Bessemer City, North Carolina.”

He added that Adtec’s service offering would now be complemented by Tosaf’s many additional proprietary products as well as its extensive R&D capabilities.

Mahesh Parikh, founder and CEO of Adtec Colorant, said the acquisition would provide his company with rapid growth and enhance its products and technologies.

Tosaf is a joint venture between Megides Holding and Belgian plastics group Ravago with 10 manufacturing plants in Israel, Turkey, Germany, the Netherlands, the UK and China.

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.